Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NeuroBo Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 101K | $318K | $3.13 | Jul 27, 2023 | Direct |
NeuroBo Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 96.4K | $302K | $3.13 | Jul 27, 2023 | Held by The E&Healthcare Investment Fund II |
NeuroBo Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 62.2K | $195K | $3.13 | Jul 27, 2023 | Held by The E&Healthcare Investment Fund No. 7 |
NeuroBo Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 37.4K | $117K | $3.13 | Jul 27, 2023 | Held by The E&Healthcare Investment Fund No. 6 |
NeuroBo Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 4.67K | $14.6K | $3.13 | Jul 27, 2023 | Held by E&Investment Inc. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NRBO | NeuroBo Pharmaceuticals, Inc. | Jul 27, 2023 | 2 | $0 | 4 | Jul 28, 2023 | Director, 10%+ Owner |
NRBO | NeuroBo Pharmaceuticals, Inc. | Jul 26, 2022 | 1 | $0 | 4/A | Jul 28, 2023 | Director, 10%+ Owner |
NRBO | NeuroBo Pharmaceuticals, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director, 10%+ Owner |